Michael Clark
9Patents
6h-index
9Co-inventors
56Inventor score
Filing activity: Sep 16, 1991 → Nov 21, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5585097A | Humanized anti-CD3 specific antibodies | Chemistry; Metallurgy | 169 | Expired |
| US6706265B1 | Humanized anti-CD3 specific antibodies | Chemistry; Metallurgy | 105 | Expired |
| US7597889B1 | Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis | Chemistry; Metallurgy | 53 | Expired |
| US5846534A | Antibodies to the antigen campath-1 | Chemistry; Metallurgy | 38 | Expired |
| US6569430B1 | Antibodies to the antigen Campath-1 | Chemistry; Metallurgy | 27 | Expired |
| US6767996B1 | Altered antibodies and their preparation | Chemistry; Metallurgy | 13 | Expired |
| USRE43898E1 | Altered antibodies and their preparation | General | 2 | Expired |
| US7098006B1 | Chimeric antibody, pharmaceutical composition and process of its production | Chemistry; Metallurgy | 1 | Expired |
| USRE46877E1 | Altered antibodies and their preparation | General | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.